                         SEQUENCE LISTING

<110>  BCN BIOSCIENCES LLC
 
<120>  METHODS OF TREATMENT USING BCN057, BCN077 AND ANALOGS

<130>  BC1-008WO

<140>  PCT/US2022/042662
<141>  2022-09-06

<160>  6     

<170>  PatentIn version 3.5

<210>  1
<211>  20
<212>  DNA
<213>  artificial

<220>
<223>  Primer - h-LGR-5 (forward)

<400>  1
tcagtcagct gctcccgaat                                                   20


<210>  2
<211>  20
<212>  DNA
<213>  artificial

<220>
<223>  Primer - h-LGR-5 (reverse)

<400>  2
cgtttcccgc aagacgtaac                                                   20


<210>  3
<211>  30
<212>  DNA
<213>  artificial

<220>
<223>  Primer - h-BMI-1 (forward)

<400>  3
atgcatcgaa caacgagaat caagatcact                                        30


<210>  4
<211>  24
<212>  DNA
<213>  artificial

<220>
<223>  Primer - h-BMI-1 (reverse)

<400>  4
tcaaccagaa gttgctgatg accc                                              24


<210>  5
<211>  22
<212>  DNA
<213>  artificial

<220>
<223>  Primer - H-Actin-b (forward)

<400>  5
tggatcagca agcaggagta tg                                                22


<210>  6
<211>  18
<212>  DNA
<213>  artificial

<220>
<223>  Primer - H-Actin-b (reverse)

<400>  6
gcatttgcgg tggacgat                                                     18


